SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA). The award, announced on July 7, 2026, recognizes the company's work in developing and commercializing robotic surgery technology (link).
SS Innovations was selected over nine other finalists, including several established medical technology companies active in robotic surgery. The recognition provides an independent industry endorsement as the company continues to expand its presence in the rapidly growing global surgical robotics market.
The award comes as adoption of the SSi Mantra surgical robotic system continues to expand, with more than 11,700 procedures completed globally. The system has received regulatory approvals in 14 countries, supporting the company's international growth strategy. More than 2,100 physicians have been trained on the platform, which has been used across over 170 different procedures.
The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties and manufacturers seek to expand beyond traditional markets. For investors, the SRIA award signifies a notable achievement for SS Innovations, which is competing against larger, more established players in the space.
Forward-looking statements in this article are subject to risks and uncertainties, including those detailed in the company's SEC filings. Undue reliance should not be placed on such statements, and the company undertakes no duty to update this information unless required by law.
